ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Endometrial Cancer
Breast Cancer
Recurrence

Prostate Cancer trials near Boston, MA, USA:

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

(ADT) in the treatment of metastatic, non-metastatic, and advanced prostate cancers. The first phase of the study is to establish a...

Active, not recruiting
Metastatic Prostate Cancer
Non-metastatic Prostate Cancer
Drug: GNRH-A Goserelin
Drug: Abemaciclib

Phase 1, Phase 2

Praful Ravi, MB BCHir, MRCP

Boston, Massachusetts, United States

This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer.The drug involved ...

Active, not recruiting
Prostate Cancer
Drug: Nivolumab

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Boston, Massachusetts, United States and 4 other locations

with the radioligand treatment, 177Lu-PSMA-617, is safe in treating prostate cancer and whether the combination is effective in shr ...

Enrolling
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Drug: 177Lu-PSMA-617
Drug: Carboplatin

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 2 other locations

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Boston, Massachusetts, United States and 92 other locations

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

Providence, Rhode Island, United States and 15 other locations

improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (A...

Enrolling
Prostate Cancer Metastatic
Prostate Cancer
Other: Aerobic and resistance exercise
Other: Usual Care
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Boston, Massachusetts, United States and 7 other locations

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110 in Combination with Abiraterone

Phase 1

Arvinas
Arvinas

Boston, Massachusetts, United States and 17 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Enrolling
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Boston, Massachusetts, United States and 9 other locations

The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to su...

Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer
Radiation: Radium 223
Drug: Docetaxel

Phase 1

Tufts University
Tufts University

Boston, Massachusetts, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems